Carbohydrates are fundamental molecules involved in nearly all aspects of lives, such as
being involved in formating the genetic and energy materials, supporting the structure of …

Glycaemic variability is an integral component of glucose homoeostasis. Although it has not
yet been definitively confirmed as an independent risk factor for diabetes complications …

Glycemic variability (GV), defined as an integral component of glucose homoeostasis, is
emerging as an important metric to consider when assessing glycemic control in clinical …

Abstract Supplementary Table S1 Continuous Glucose Monitoring (CGM) has been
demonstrated to be clinically valuable, reducing risks of hypoglycemia and hyperglycemia …

Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications
shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood …

OBJECTIVE Evaluate the efficacy and safety of the dual sodium–glucose cotransporter 1
(SGLT1) and SGLT2 inhibitor sotagliflozin in combination with optimized insulin in type 1 …

Endothelial dysfunction plays a critical role in atherosclerosis progression, leading to
cardiovascular complications. There are significant associations between diabetes mellitus …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

OBJECTIVE To evaluate real-world efficacy and safety of sodium–glucose cotransporter 2
inhibitor (SGLT2i) use in combination with insulin in people with type 1 diabetes …

The efficacy of diabetes treatment should not be evaluated solely by HbA1c levels as they
should also focus on patient-reported outcomes (PROs), such as patient satisfaction …